Rojas-Giménez, M.; Muñoz-Reinoso, P.; Arcila-Durán, M.D.; Moreira-Navarrete, V.; López, M.M.; Fernández-Alba, M.D.; Ariza-Ariza, R.; Decan-Bardasz, M.D.; Cruz, B.H.; Toyos, F.J.;
et al. An Analysis of Major Adverse Cardiovascular Events, Other Adverse Events, and Efficacy in Patients with Rheumatic Disease Receiving Targeted Therapy: Experience from a Third-Level Hospital. J. Clin. Med. 2025, 14, 4693.
https://doi.org/10.3390/jcm14134693
AMA Style
Rojas-Giménez M, Muñoz-Reinoso P, Arcila-Durán MD, Moreira-Navarrete V, López MM, Fernández-Alba MD, Ariza-Ariza R, Decan-Bardasz MD, Cruz BH, Toyos FJ,
et al. An Analysis of Major Adverse Cardiovascular Events, Other Adverse Events, and Efficacy in Patients with Rheumatic Disease Receiving Targeted Therapy: Experience from a Third-Level Hospital. Journal of Clinical Medicine. 2025; 14(13):4693.
https://doi.org/10.3390/jcm14134693
Chicago/Turabian Style
Rojas-Giménez, Marta, Paloma Muñoz-Reinoso, MarÃa Dolores Arcila-Durán, Virginia Moreira-Navarrete, Manuel Maqueda López, MarÃa Dolores Fernández-Alba, Rafael Ariza-Ariza, Maria Daniela Decan-Bardasz, Blanca Hernández Cruz, Francisco Javier Toyos,
and et al. 2025. "An Analysis of Major Adverse Cardiovascular Events, Other Adverse Events, and Efficacy in Patients with Rheumatic Disease Receiving Targeted Therapy: Experience from a Third-Level Hospital" Journal of Clinical Medicine 14, no. 13: 4693.
https://doi.org/10.3390/jcm14134693
APA Style
Rojas-Giménez, M., Muñoz-Reinoso, P., Arcila-Durán, M. D., Moreira-Navarrete, V., López, M. M., Fernández-Alba, M. D., Ariza-Ariza, R., Decan-Bardasz, M. D., Cruz, B. H., Toyos, F. J., Mendoza, D. V. M., & Venegas, J. J. P.
(2025). An Analysis of Major Adverse Cardiovascular Events, Other Adverse Events, and Efficacy in Patients with Rheumatic Disease Receiving Targeted Therapy: Experience from a Third-Level Hospital. Journal of Clinical Medicine, 14(13), 4693.
https://doi.org/10.3390/jcm14134693
